You are here: Industry Insights > blood clots

News List

NIH launches antithrombotics trials in COVID-19 patients europeanpharmaceuticalreview
September 16, 2020
The adaptive Phase III trials will assess whether various types and doses of blood thinners can prevent COVID-19 patients forming potentially fatal blood clots.
The dark side of anticoagulants: will a new approach shed any light? pharmaceutical-technology
June 17, 2020
Anticoagulants are life-saving medicines, but they also raise the risk of patients haemorrhaging and bleeding to death.
How to Keep Those Blood Vessels Pumping drugs
January 19, 2020
Want to know how to avoid blood clots and varicose veins? One physician offers some tips on how to keep your blood vessels healthy.
World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots En-CPhI.CN
October 11, 2019
On October 13, the World Thrombosis Day campaign shares an important message: patients, regardless of where they live ...
FDA Approves Boxed Warning about Increased Risk of Blood Clots, Death with Xeljanz americanpharmaceuticalreview
July 30, 2019
The U.S. Food and Drug Administration (FDA) has approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR) ...
Safety Trial Finds Risk of Blood Clots in Lungs and Death with Higher Dose of Tofacitinib in RA Patients; FDA to Investigate americanpharmaceuticalreview
February 27, 2019
The U.S. Food and Drug Administration (FDA) is alerting the public that a safety clinical trial found an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of tofacitinib ....
Decoy platelets could prevent clots and cancer spread pharmaceutical-technology
February 15, 2019
Researchers at the Wyss Institute at Harvard University have created ‘decoy’ platelets that could potentially reduce blood clots, as well as prevent cancer from spreading....
Rivaroxaban reduced blood clots and related death in cancer patients europeanpharmaceuticalreview
December 05, 2018
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths…

Previous page 1 2 Next page